Dr. Martens plc
DOCS.L · LSE
9/30/2025 | 3/31/2025 | 3/30/2025 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | – | £482 | – | £532 |
| - Cash | £96 | £156 | – | £95 |
| + Debt | £348 | £404 | – | £450 |
| Enterprise Value | – | £730 | – | £887 |
| Revenue | £322 | – | £463 | £325 |
| % Growth | – | – | 42.6% | – |
| Gross Profit | £176 | – | £304 | £208 |
| % Margin | 54.6% | – | 65.7% | 64% |
| EBITDA | £38 | – | £115 | -£5 |
| % Margin | 11.7% | – | 24.8% | -1.4% |
| Net Income | -£10 | – | £25 | -£21 |
| % Margin | -3.1% | – | 5.5% | -6.4% |
| EPS Diluted | -0.01 | – | 0.026 | -0.022 |
| % Growth | – | – | 219.1% | – |
| Operating Cash Flow | -£16 | – | £143 | £35 |
| Capital Expenditures | -£4 | – | -£4 | -£4 |
| Free Cash Flow | -£20 | – | £138 | £31 |